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Clinical v. laboratory-based screening 
for COVID-19 in asymptomatic 
patients requiring acute cardiac care
To the Editor: Tygerberg Academic Hospital (TBH) and its network 
of satellite hospitals provide coronary care to 2.4 million people in 
and around Cape Town, South Africa.[1] At the height of the COVID-
19 pandemic, weekly admissions to our coronary care unit (CCU) 
fell by 46% compared with the previous year, only returning to 
pre-COVID-19 levels after easing of the hard lockdown. [2] This post-
hard lockdown period was particularly challenging, as COVID-19 
admissions to TBH increased further, competing with higher numbers 
of CCU patients for limited bed space. To prevent nosocomial 
spread of COVID-19 in the CCU and protect staff working in this 
essential acute service, we aimed to maintain our CCU as a low-risk 
COVID-19 area. While nasopharyngeal swab polymerase chain 
reaction (PCR) remains the gold standard for diagnosing COVID-19 
infection, its sensitivity for diagnosing acute infection is relatively 
low in symptomatic patients and its performance in asymptomatic 
patients remains largely unknown.[3,4] Furthermore, it is unclear 
whether clinical screening without nasopharyngeal swab PCR is a 
sufficient strategy to minimise nosocomial transmission.
Our initial strategy was selective PCR testing. All patients referred 
to the Division of Cardiology at TBH were screened for symptoms 
of COVID-19 infection and underwent nasopharyngeal swab testing 
based on symptom profile. Patients with proven current COVID-19 
infection and those in whom there was high clinical suspicion were 
admitted to a dedicated COVID-19 ward or single isolation rooms in 
the CCU pending their PCR swab results. Emergency interventions 
were performed using full PPE.[5] During a 4-week period from 
8 July to 5 August 2020, at the peak of the Cape Town pandemic,[6] 
our selective testing strategy was changed to a strategy of testing all 
patients admitted to the CCU, including those without COVID-19 
symptoms. The rationale for this change was the perception that there 
may be a significant number of asymptomatic COVID-19-positive 
patients at the height of the pandemic. Surveillance testing, as it was 
termed, did not influence patient management in any way.
During this period, 116 asymptomatic patients were admitted to 
the CCU; 89 surveillance swabs were performed (77% of admissions), 
with similar numbers performed in the CCU (46%) and at our 
referral hospitals (54%).
Of the 89 surveillance swabs, 3 (3.4%) were positive for COVID-
19. The swab-positive patients were isolated in single rooms in the 
CCU after the test result became available. Two patients underwent 
percutaneous coronary intervention, while the third underwent 
inpatient coronary bypass surgery after 10 days of isolation. None of 
these patients developed symptoms or adverse events during their 
admission, and all were discharged home, well. We did not see an 
increase in healthcare worker infections in the CCU, and there was 
no evidence of nosocomial spread to patients.
Our findings are reassuring for clinicians (and patients) attempting 
to return to normal practice. The number of asymptomatic patients 
with underlying COVID-19 infection admitted to hospital, even at 
the peak of the pandemic, appears to be low. Furthermore, our data 
are in keeping with recent reports that asymptomatic patients do not 
pose an increased risk for nosocomial spread of COVID-19, as long 
as basic COVID-19 care principles are adhered to.[7,8]
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